跳至主要内容
临床试验/EUCTR2013-002396-17-GB
EUCTR2013-002396-17-GB进行中(未招募)1 期

The effect of Pramipexole on recovery from chronic post-stroke aphasia - Pramipexole in aphasia

Birmingham Community Healthcare NHS Trust0 个研究点目标入组 40 人开始时间: 2013年8月2日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • First-ever stroke at least 6 months prior to the start of the study and resulting in severe or moderately severe predominantly expressive aphasia.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 10
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 30

排除标准

  • Parkinson’s disease
  • Major depressive illness
  • Significant cognitive impairment
  • Severe renal impairment
  • Known hypersensitivity to dopamine agonists, pregnancy, breast feeding or psychosis Patients for whom English is not the first language will also be excluded because of concerns about the validity and reliability of the translated versions of the Western Aphasia Battery.

研究者

发起方
Birmingham Community Healthcare NHS Trust

相似试验